Herein, we aimed to test the following hypotheses: First, we hypothesized that IRF4, in addition to its acute anti-inflammatory role, limits the chronic inflammatory response, residual renal damage, and renal fibrosis. The gene discussed is IRF4; the disease is renal fibrosis.